EVOLUS, INC. Increase (Decrease) in Accounts Receivable
EVOLUS, INC. (EOLS) reported Increase (Decrease) in Accounts Receivable of $8.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- EVOLUS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $10.94M, a 1042.07% increase year-over-year.
- EVOLUS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$2.15M, a 361.73% decline year-over-year.
- EVOLUS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $4.79M, a 25.15% increase year-over-year.
- EVOLUS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $4.94M, a 107.13% increase year-over-year.
- EVOLUS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $11.51M, a 41.29% decline from fiscal 2024.
- EVOLUS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $19.60M, a 105.88% increase from fiscal 2023.
- EVOLUS, INC. increase (decrease) in accounts receivable for fiscal 2023 was $9.52M, a 1.41% increase from fiscal 2022.
- EVOLUS, INC. increase (decrease) in accounts receivable for fiscal 2022 was $9.39M, a 68.68% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $8.79M 10-Q · filed 2026-08-05 | $13.58M derived: sum of 3 quarters · filed 2026-08-05 | $18.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$2.15M 10-Q · filed 2026-05-04 | $2.64M derived: sum of 2 quarters · filed 2026-05-04 | $7.57M derived: sum of 3 quarters · filed 2026-05-04 | $8.53M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $9.73M derived: sum of 2 quarters · filed 2026-03-03 | $10.69M derived: sum of 3 quarters · filed 2026-08-05 | $11.51M 10-K · filed 2026-03-03 |
| 2025-09-30 | $4.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.89M derived: sum of 2 quarters · filed 2026-08-05 | $6.72M 10-Q · filed 2025-11-05 | $10.55M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $958.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.78M 10-Q · filed 2026-08-05 | $5.61M derived: sum of 3 quarters · filed 2026-08-05 | $7.99M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $823.00K 10-Q · filed 2026-05-04 | $4.65M derived: sum of 2 quarters · filed 2026-05-04 | $7.04M derived: sum of 3 quarters · filed 2026-05-04 | $16.53M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $6.21M derived: sum of 2 quarters · filed 2026-03-03 | $15.70M derived: sum of 3 quarters · filed 2026-03-03 | $19.60M 10-K · filed 2026-03-03 |
| 2024-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.87M derived: sum of 2 quarters · filed 2025-11-05 | $15.77M 10-Q · filed 2025-11-05 | $15.92M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $9.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $13.39M 10-Q · filed 2025-08-05 | $13.54M derived: sum of 3 quarters · filed 2026-03-03 | $16.02M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $3.90M 10-Q · filed 2025-05-07 | $4.05M derived: sum of 2 quarters · filed 2026-03-03 | $6.53M derived: sum of 3 quarters · filed 2026-03-03 | $12.14M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.63M derived: sum of 2 quarters · filed 2026-03-03 | $8.24M derived: sum of 3 quarters · filed 2026-03-03 | $9.52M 10-K · filed 2026-03-03 |
| 2023-09-30 | $2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $8.09M derived: sum of 2 quarters · filed 2024-11-06 | $9.37M 10-Q · filed 2024-11-06 | $11.13M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $5.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $6.89M 10-Q · filed 2024-07-31 | $8.65M derived: sum of 3 quarters · filed 2025-03-04 | $9.17M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $1.28M 10-Q · filed 2024-05-07 | $3.04M derived: sum of 2 quarters · filed 2025-03-04 | $3.56M derived: sum of 3 quarters · filed 2025-03-04 | $8.06M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $2.28M derived: sum of 2 quarters · filed 2025-03-04 | $6.78M derived: sum of 3 quarters · filed 2025-03-04 | $9.39M 10-K · filed 2025-03-04 |
| 2022-09-30 | $518.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $5.02M derived: sum of 2 quarters · filed 2023-11-07 | $7.63M 10-Q · filed 2023-11-07 | $9.08M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $7.11M 10-Q · filed 2023-08-02 | $8.56M derived: sum of 3 quarters · filed 2023-08-02 | $10.18M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $2.61M 10-Q · filed 2023-05-09 | $4.06M derived: sum of 2 quarters · filed 2023-05-09 | $5.68M derived: sum of 3 quarters · filed 2023-05-09 | $9.43M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $3.07M derived: sum of 2 quarters · filed 2023-03-08 | $6.82M derived: sum of 3 quarters · filed 2023-03-08 | $5.57M 10-K · filed 2023-03-08 |
| 2021-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $5.36M derived: sum of 2 quarters · filed 2022-11-08 | $4.11M 10-Q · filed 2022-11-08 | $2.02M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $2.50M 10-Q · filed 2022-08-02 | $405.00K derived: sum of 3 quarters · filed 2022-08-02 | $2.99M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | -$1.25M 10-Q · filed 2022-05-10 | -$3.35M derived: sum of 2 quarters · filed 2022-05-10 | -$764.00K derived: sum of 3 quarters · filed 2022-05-10 | -$2.52M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $490.00K derived: sum of 2 quarters · filed 2022-03-03 | -$1.27M derived: sum of 3 quarters · filed 2022-03-03 | $1.08M 10-K · filed 2022-03-03 |
| 2020-09-30 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $825.00K derived: sum of 2 quarters · filed 2021-11-02 | $3.18M 10-Q · filed 2021-11-02 | $7.02M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | -$1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $595.00K 10-Q · filed 2021-08-04 | $4.44M derived: sum of 3 quarters · filed 2021-08-04 | $10.23M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $2.35M 10-Q · filed 2021-05-12 | $6.19M derived: sum of 2 quarters · filed 2021-05-12 | $11.99M derived: sum of 3 quarters · filed 2021-05-12 | $13.40M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $9.64M derived: sum of 2 quarters · filed 2021-03-25 | $11.05M derived: sum of 3 quarters · filed 2021-03-25 | $11.05M 10-K · filed 2021-03-25 |
| 2019-09-30 | $5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $7.21M derived: sum of 2 quarters · filed 2020-10-29 | $7.21M 10-Q · filed 2020-10-29 | $7.21M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.41M 10-Q · filed 2020-08-10 | $1.41M derived: sum of 3 quarters · filed 2020-08-10 | $1.41M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2020-05-11 | $0.00 derived: sum of 3 quarters · filed 2020-05-11 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |